AbbVie Inc. — Director's Dealing 2021

May 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-05-03

Reporting Person: Strom Carrie C (SVP & Pres Global Allerg Aesth)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-03	Common Stock, $0.01 par value	M	4184	$41.39	Acquired	63409	Direct
2021-05-03	Common Stock, $0.01 par value	S	4184	$112.4	Disposed	59225	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-03	Option (right to buy)	$41.39	M	4184	Disposed	2021-08-05	Common Stock (4184)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.